Agave syrup formulation or suspension for active pharmaceutical agents
AssigneeGenenxa Inc.
InventorsMax Spielberg, David Johnson
Life of this patent
Estimating the term…
Abstract
The present invention relates to an aqueous pharmaceutical suspension composition having from about 0.2% to 20% of a substantially water soluble pharmaceutical active, e.g. acetaminophen; a suspension stabilizing effective amount of xanthan gum and microcrystalline cellulose; an effective amount of taste masking compositions; and water, as well as a process for producing such aqueous pharmaceutical suspensions.
Claims26
A pharmaceutical syrup formulation for oral administration comprising:
- (a) an active pharmaceutical agent,
- (b) agave syrup, and
- (c) a water-based diluent, wherein the syrup formulation has a viscosity of less than 1000 centipoise at about 22 degrees;
- wherein the active pharmaceutical agent is suspended in the syrup;
- and wherein the syrup is palatable.
A stable pharmaceutical syrup formulation for oral administration consisting essentially of:
- (a) an active pharmaceutical agent;
- (b) agave syrup;
- (c) a preservative to extend shelf life;
- (d) a flavoring agent to enhance palatability, and
- (e) a water-based diluent, wherein the formulation is maintained with a viscosity of less than 1000 centipoise at about 22 degrees Celsius, with the active pharmaceutical agent effectively suspended in the syrup.
The pharmaceutical syrup formulation of claim 18, wherein the acidic preservative comprises citric acid.
A stable, palatable pharmaceutical syrup formulation for oral administration consisting of:
- (a) a therapeutically effective amount of an active pharmaceutical agent;
- (b) agave syrup;
- (b) an acidic preservative;
- (c) a flavoring agent, and
- (d) a diluent, wherein the syrup formulation has a viscosity of less than 1000 centipoise at about 22 degrees and the active pharmaceutical agent is suspended in the syrup.
Dependencies are inferred from the claim text.